Work

A phase I dose‐ranging study of bendamustine and rituximab in chronic lymphocytic leukemia patients with comorbidities

Year: 2016

Type: article

Abstract: The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in haematology and Letters to the Editor.

Source: British Journal of Haematology

DOI: 10.1111/bjh.14171

Authors: Alexey V. Danilov, Lionel D. Lewis, Frederick Lansigan, Liya Roudaia, Darcie L. Findley, Susan Y. Jones, Brian Highhouse, Bernard B. Beaulieu, Jennifer R. Brown

Institutions: Oregon Health & Science University, OHSU Knight Cancer Institute, Dartmouth Cancer Center, Dana-Farber Cancer Institute

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute

Award: G3853912554

OpenAlex ID: W2463153294

FWCI: 0.398

Cites: 10

Cited by: 4

Related to: 10